VERU vs. NATR, FHTX, CDT, ME, ACIU, EBS, QURE, ALDX, HOWL, and PBYI
Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Foghorn Therapeutics (FHTX), Conduit Pharmaceuticals (CDT), 23andMe (ME), AC Immune (ACIU), Emergent BioSolutions (EBS), uniQure (QURE), Aldeyra Therapeutics (ALDX), Werewolf Therapeutics (HOWL), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical preparations" industry.
Nature's Sunshine Products (NASDAQ:NATR) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, community ranking, valuation, dividends and profitability.
Veru received 109 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 69.59% of users gave Veru an outperform vote while only 62.89% of users gave Nature's Sunshine Products an outperform vote.
Nature's Sunshine Products has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Veru has a beta of -0.47, meaning that its share price is 147% less volatile than the S&P 500.
Nature's Sunshine Products has a net margin of 3.69% compared to Nature's Sunshine Products' net margin of -265.27%. Veru's return on equity of 10.59% beat Nature's Sunshine Products' return on equity.
Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.
Nature's Sunshine Products currently has a consensus target price of $24.00, indicating a potential upside of 51.80%. Veru has a consensus target price of $4.00, indicating a potential upside of 171.19%. Given Nature's Sunshine Products' higher probable upside, analysts plainly believe Veru is more favorable than Nature's Sunshine Products.
79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 47.2% of Veru shares are owned by institutional investors. 4.9% of Nature's Sunshine Products shares are owned by company insiders. Comparatively, 14.2% of Veru shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, Veru had 7 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 14 mentions for Veru and 7 mentions for Nature's Sunshine Products. Veru's average media sentiment score of 1.27 beat Nature's Sunshine Products' score of 0.33 indicating that Nature's Sunshine Products is being referred to more favorably in the media.
Summary
Nature's Sunshine Products beats Veru on 11 of the 18 factors compared between the two stocks.
Get Veru News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
